# Addressing Challenges in Detecting New Drugs: Instrumentation for Alternative Analytical Methods (R41/R42 - Clinical Trials Optional)

Source: https://welltoldgrants.com/grants/rfa-da-26-019-addressing-challenges-in-detecting-new-drugs/  
Official notice: https://www.grants.gov/search-results-detail/356963

> National Institutes of Health offered grants to small businesses. Applications closed on February 19, 2025.

| Field | Value |
|---|---|
| Opportunity number | RFA-DA-26-019 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | February 19, 2025 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.279 |

## Who can apply

- Small businesses

Other Eligible Applicants include the following: See NOFO for further Eligibility Requirements.

## What the grant funds

Emerging threats continuously evolve. Xylazine, nitazenes, and other future threats are making their way or are already in the drug supply. Understanding them requires analyzing real world samples. Typically, testing strips are used to detect drug for which such strip exists, as the strips are fast, sensitive, low cost and reasonably accurate. However, as there might not be testing strips for the new threats, the analysis must be performed via sensitive and sample agnostic methods.

## Questions people ask

### Is RFA-DA-26-019 still open?

No. It closed on February 19, 2025.

### Who can apply for Addressing Challenges in Detecting New Drugs: Instrumentation for Alternative Analytical Methods (R41/R42 - Clinical Trials Optional)?

National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Addressing Challenges in Detecting New Drugs: Instrumentation for Alternative Analytical Methods (R41/R42 - Clinical Trials Optional)?

Closed February 19, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has won Drug Use and Addiction Research Programs grants before?

The largest recipients over five fiscal years were Yale Univ, The Johns Hopkins University, University of California, San Diego. The program made 5,071 awards worth $7.3 billion in that time.
